ARNIs May Reduce Mortality and Cardiac Events in Lung Cancer Patients Treated With ICIs: Study
China: Use of angiotensin receptor–neprilysin inhibitors (ARNIs) in lung cancer patients with hypertension receiving immune checkpoint inhibitors (ICIs) was associated with lower all-cause mortality, while rates of cardiac events were…